Financings

Financings for Jan. 28, 2020

January 28, 2020

Med-tech firms raising money in public or private financings, including: Cerus, Co-Diagnostics

Financings for Jan. 28, 2020

January 28, 2020

Biopharmas raising money in public or private financings, including: Applied Therapeutics, Autolus, Concert, Denali, Immunogen, Intelgenx, Vascular Therapies, Vaxil, Xenon

Financings for Jan. 27, 2020

January 27, 2020

No Comments

Med-tech firms raising money in public or private financings, including: Loop+, Pharmaceutical Product Development, Ulab Systems, Valencell

Elypta reels in €6.1M to advance liquid biopsy platform

January 27, 2020

By Meg Bryant

No Comments

Liquid biopsy startup Elypta AB has raised €6.1 million (US$6.72 million) in a late seed financing led by Industrifonden and Sciety. Norrsken Foundation’s newly launched €100 million “impact-first” fund also contributed to the round. The Stockholm-based company plans to use the money to complete development of laboratory kits and software for measurement and analysis of a panel of metabolites it has identified.

Med-tech U.S. IPOs up 40% on average in 2019, with $3B total raised

January 27, 2020

By Karen Carey

No Comments

The final scorecard for med-tech IPOs in 2019 shows that Lake Forest, Calif.-based Inmode Ltd. performed the best since its August debut, while San Diego-based Guardion Health Sciences Inc. lost the most stock value during the year.

Financings for Jan. 27, 2020

January 27, 2020

No Comments

Biopharmas raising money in public or private financings, including: Adaptimmune, Arix, Beam, Quench Bio, Nanoviricides, Vaccibody, Zymeworks

Financings for Jan. 24, 2020

January 24, 2020

No Comments

Med-tech firms raising money in public or private financings, including: Adaptive Biotechnologies, CHF Solutions, Co-Diagnostics, Kane Biotech

Financings for Jan. 24, 2020

January 24, 2020

No Comments

Biopharmas raising money in public or private financings, including: Applied Therapeutics

Financings for Jan. 23, 2020

January 23, 2020

No Comments

Med-tech firms raising money in public or private financings, including: Elypta, Misonix, Sequana Medical, SI-Bone

Precision Medicine World Conference

Novel Dx companies start to see a better path with payers, but continue to work all the angles

January 23, 2020

By Stacy Lawrence

No Comments

SANTA CLARA, Calif. – It has never been easy to get payers to reimburse in a timely and adequate fashion for novel diagnostics, making it notoriously difficult to build a business from them. But a few high-flying diagnostics companies, such as Madison, Wis.-based Exact Sciences Corp. and Redwood City, Calif.-based Guardant Health Inc., have been blazing the trail recently on how to rapidly scale up to become valuable commercial entities from origins as a research-based startup.